Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.46 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.46 |
| ▸ | BCHE | P06276 | 3/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11060563 | 0.83 | CYP1A2 (0.58) | ALDH1A1RAB9AGAAMEN1KMT2A | |
| SCHEMBL27572461 | 0.76 | RAB9A (0.45) | RAB9AKDM4EGAAL3MBTL1MEN1 | |
| SCHEMBL869828 | 0.75 | FFAR1 (0.43) | L3MBTL1MEN1KMT2AMTNR1AMTNR1B | |
| SCHEMBL13572927 | 0.74 | ATM (0.59) | RAB9AMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL14999596 | 0.74 | ATM (0.59) | RAB9AMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL6407665 | 0.74 | ATM (0.59) | RAB9AMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL6693558 | 0.73 | MAPT (0.44) | L3MBTL1MTNR1AMTNR1B | |
| SCHEMBL3640380 | 0.73 | TDP1 (0.41) | ALDH1A1GAAL3MBTL1MEN1KMT2A | |
| SCHEMBL19591984 | 0.71 | POLB (0.76) | ALDH1A1KDM4EL3MBTL1MEN1KMT2A | |
| SCHEMBL24116761 | 0.71 | POLB (0.60) | ALDH1A1RAB9AGAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023064493-A1 | COMPOUNDS AND METHODS FOR TREATING CORONAVIRUSES | Clear Creek Bio, Inc. (US) | 2023-04-20 | — | — | WO | disclosed |